Signet Investment Advisory Group, Inc. Hoth Therapeutics, Inc. Transaction History

Signet Investment Advisory Group, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$0.38 - $1.05 $3,800 - $10,500	-10,000 Closed	0 $0
Q1 2022 May 03, 2022	SELL	$0.52 - $1.3 $5,200 - $13,000	-10,000 Reduced 50.0%	10,000 $7,000
Q2 2021 Jul 26, 2021	BUY	$1.31 - $2.14 $26,200 - $42,800	20,000 New	20,000 $32,000

Ticker HOTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,288,470
Market Cap $1.11M
Description
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor ...

Get notified when there are updates to the investment portfolio of Signet Investment Advisory Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Signet Investment Advisory Group, Inc. with notifications on news.